tiprankstipranks
Trending News
More News >

Jazz Pharmaceuticals says EC grants marketing authorization for Ziihera

Jazz Pharmaceuticals (JAZZ) announced that the European Commission has granted conditional marketing authorization for Ziihera, a dual human epidermal growth factor receptor 2-targeted bispecific antibody, as monotherapy for the treatment of adults with unresectable locally advanced or metastatic HER2-positive biliary tract cancer previously treated with at least one prior line of systemic therapy.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1